The Xstrahl 200 X-ray Treatment System has been installed in Uzbekistan by Nozomi Medical. Hear Dr. Mamarasulov provide his feedback and review of the Xstrahl 200.
Xstrahl 200 X-ray Treatment System Review
read more
Radiation Therapy
XBeam from Xstrahl Receives U.S. Food and Drug Administration (FDA) 510(k) Clearance for Use in the U.S.
Xstrahl’s XBeam has received FDA 510(k) Clearance for Use in the U.S. The XBeam technology streamlines radiotherapy treatment planning and simplifies patient workflow for treating skin cancer, benign diseases, and palliative care. Explore how this innovation enhances orthovoltage superficial radiotherapy (SRT) and electronic brachytherapy (eBt). With XBeam, you can calculate, protocol and export treatment plans for Xstrahl treatments with Radiant Aura and all other Xstrahl medical devices in the U.S. and worldwide.
Xstrahl to Attend VCS and ASDS Conferences in Orlando
Xstrahl to Attend VCS and ASDS Conferences in Orlando: The recent hurricanes have affected so many, and the team at Xstrahl hopes that you and your family are safe. Our hearts go out to everyone as they face this difficult time ahead. Prior to the hurricanes, Xstrahl committed to attending two conferences in Orlando, FL this week, and organizers of the conferences have confirmed that they will still be happening. If you are attending either conference in Orlando, please visit our team to say hello. We’d love to meet you.
Xstrahl Presented at the 11th Congress of Radiological Technologists of R. N. Macedonia
Xstrahl presented The role of radiation technologists as a radiotherapy treatment at the 11th Congress of Radiological Technologists of R. N. Macedonia
Xstrahl to Spotlight Superficial and Orthovoltage Radiotherapy Solutions for Skin Cancer and Benign Conditions at ASTRO 2024
Xstrahl, a global leader in the delivery of superficial radiation therapy devices and preclinical radiation research systems, will demonstrate Xstrahl 200, a modern orthovoltage radiotherapy solution for treating superficial lesions, skin cancers, and selective benign conditions at the 2024 American Society for Therapeutic Radiology and Oncology (ASTRO) Annual Meeting in Washington, DC Sept. 29-Oct 2, 2024, at booth #1937.
Grenz Radiation Therapy Commissioning for Medical Physicists
In this webinar, Kurt Byrnes, Radiation Oncology Medical Physicist at Just Skin in Australia provides an overview of his experience of commissioning grenz rays on the Xstrahl X100 system following the AAPM TG61 protocol. He covers protocol comparison, half value layer...
SmART-RAD Overview
Accurate dosimetry and reporting is the best practice in radiation research. Based on a powerful Monte Carlo dose engine, SmART-RAD is an easy-to-use solution that gives users the tools to determine and understand how irradiation parameters impact the delivered dose....
Xstrahl to Highlight Superficial and Orthovoltage Radiotherapy Solutions for Skin Cancer and Selective Benign Conditions at AAPM 2024
Xstrahl, a global leader in the delivery of superficial radiation therapy devices and preclinical radiation research systems, will demonstrate Xstrahl 200, a modern orthovoltage radiotherapy solution for treating superficial lesions, skin cancers, and selective benign conditions at the 66th Annual Meeting & Exhibition of the American Association of Physicists in Medicine (AAPM) in Los Angeles, CA, from July 21-25, 2024, at booth 518.
Superficial Radiation Therapy Post-Op for Keloids: Protocols, Techniques, and Outcomes
Superficial radiation therapy offers non-surgical treatment options to office-based dermatology practices to expand patient care for non-melanoma skin cancers, such as basal cell and squamous cell carcinoma, and to reduce keloid recurrence post-operatively. In this...
Contact Us